Summary
The clinical tolerance of ibopamine hydrochloride (SB 7505) was investigated in 12 volunteers. The drug was administered on alternate days (2nd, 4th, 6th, 8th, 10th, 12th), starting at 100 mg and increasing by 50 mg each time to reach 350 mg on the 12th day. On the other days (1st, 3rd, 5th, 7th, 9th, 11th and 13th) a placebo was given. Diuresis increased progressively with the dose, reaching a maximum increase of 88% after the last dose, and showing a small residual effect on each subsequent placebo day. Body weight showed a marginal change and decreased by 2% in the last two days of treatment. Heart rate, systolic, diastolic and mean blood pressure showed only marginal fluctuations of about 7% around the mean values, which were of little statistical and of no clinical significance.
Haematological and biochemical parameters were not affected. No side effect was noticed. The dose of 350 mg may probably be increased without leading to side effects.
Similar content being viewed by others
References
Melloni GF, Minoja GM, Scarazzati G, Bauer R, Brusoni B, Ghirardi P (1981) Renal effects of SB 7505: A double-blind study. Eur J Clin Pharmacol 19: 177–180
Merlo L, Brusoni B, Ghirardi P (1979) Effetti dell'Estere Diisobutirrico dell'N-Metil-Dopamina (SB 7505) sull'emodinamica del distretto renale e sulla contrattilità del miocardio del cane narcotizzato. Atti XL Congresso Soc. Ital. di Cardiol.
Ghirardi P, Bauer R, Brusoni B (1980) Effects d'un dérivé de la dopamine actif par voie orale sur l'excrétion rénale. Nouv Presse Méd 9: 453
Dei Cas L, Manca C, Vasini G, Mansour M, Bernardini B, Visioli O (1980) Non-invasive evaluation of left ventricular function through systolic time intervals following oral administration of SB 7505 in man. Arzneim.-Forsch 30: 498–500
Stefoni S, Colì L, Mosconi G, Prandini R (1981) Ibopamine (SB 7505) in normal subjects and in chronic renal failure A preliminary report. Br J Clin Pharmacol 1: 69–72
Draper N, Smith H (1966) Applied regression analysis. J. Wiley, London
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Melloni, G.F., Melloni, R., Minoja, G.M. et al. Clinical tolerability of ibopamine hydrochloride (SB 7505). Eur J Clin Pharmacol 19, 409–411 (1981). https://doi.org/10.1007/BF00548583
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00548583